Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor
Anna Mero(University of Padua), Tacey X. Viegas(Mirna Therapeutics (United States)), Zhihao Fang(Xi'an University of Architecture and Technology), Francesco M. Veronese(University of Milan), Gianfranco Pasut(University of Padua)
Cited by 80
Related Papers
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
|Bioconjugate Chemistry|2011|424
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
|European Polymer Journal|2016|175
Towards the Automatic Anime Characters Creation with Generative Adversarial Networks
|arXiv (Cornell University)|2017|136
Cascaded filter deterministic lateral displacement microchips for isolation and molecular analysis of circulating tumor cells and fusion cells
|Lab on a Chip|2021|84
Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit
|Movement Disorders|2013|68